CEMER Centro Médico de Enfermedades Respiratorias - Vicente Lopez

Esmeralda 1550, Vicente Lopez, Buenos Aires

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Gabriela Tabaj

Erik Silva

Gustavo Lopez

Cristian Micheri

Miguel Angel Bergna

Nicolás Porta

Carolina Kreimis

Amparo Martinez Ferro

Open studies

Lung cancer

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment - SAFFRON - AstraZenecaSee more

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors - GARNET - Tesaro, Inc.See more

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) - GALAXIES Lung-301 - GlaxoSmithKlineSee more

Asthma

Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma - FLASH - AstraZenecaSee more

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma - AmgenSee more

Pulmonary fibrosis

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - Bristol-Myers SquibbSee more

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - Bristol-Myers SquibbSee more

Endometrial Cancer

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors - GARNET - Tesaro, Inc.See more

Fallopian tube cancer

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors - GARNET - Tesaro, Inc.See more

Ovarian cancer

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors - GARNET - Tesaro, Inc.See more

Peritoneal cancer

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors - GARNET - Tesaro, Inc.See more

Solid tumors

Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors - GARNET - Tesaro, Inc.See more